Asston Pharmaceuticals Limited (BOM:544445)

India · Delayed Price · Currency is INR

75.00

+0.97 (1.31%)

At close: Jul 8, 2026

-36.97% (1Y)

Market Cap	638.47M
Revenue (ttm)	254.69M +1.7%
Net Income	38.65M -10.6%
EPS	4.92 -28.7%
Shares Out	8.51M
PE Ratio	15.24
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,000
Open	77.00
Previous Close	74.03
Day's Range	75.00 - 77.00
52-Week Range	61.02 - 126.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Asston Pharmaceuticals

Asston Pharmaceuticals Limited manufactures pharmaceutical products in India, West Africa, South Africa, and Asian countries. The company provides tablets, such as aceclofenac, albendazole, aminophylline, artemether and lumefantrine, ascorbic acid chewable, azithromycin, b-complex, calcium, cholecalciferol with folic acid, cefixime, cetirizine, ciprofloxacin, co-trimoxazole, cyproheptadine, dexamethasone, diclofenac, ferrous sulphate, folic acid, glucose, griseofulvin, levofloxacin, loperamide HCL, losartan potassium, mebendazole, metformin hyd... [Read more]

Industry Pharmaceutical Preparations

Founded 2019

Country India

Stock Exchange Bombay Stock Exchange

Ticker Symbol 544445

Full Company Profile

Financial Performance

In fiscal year 2026, Asston Pharmaceuticals's revenue was 254.69 million, an increase of 1.72% compared to the previous year's 250.39 million. Earnings were 38.65 million, a decrease of -10.63%.

Financial Statements